Pharmaceutical compound
Legal status | |
---|---|
Legal status | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H23NO |
Molar mass | 245.366 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
3-Methyl-alpha-PVP (3-Me-PVP, O-2480) is a substituted cathinone derivative with stimulant effects, which has been sold as a designer drug. It was first identified in Sweden in June 2023.
See also
References
- Meltzer PC, Butler D, Deschamps JR, Madras BK (February 2006). "1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors". Journal of Medicinal Chemistry. 49 (4): 1420–32. doi:10.1021/jm050797a. PMC 2602954. PMID 16480278.
- "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.